It was therefore mAb04-MICA enhanced immunosurveillance mediated by NK cells against VEGFR2 positive breast cancer cells, and the activities of immunosurveillance and inhibiting tumor were proportional to the binding of mAb04-MICA to cancer cell surface. The gene discussed is MICA; the disease is neoplasm.